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Abstract Objective: To compare GOLD classiﬁcation of COPD versus the modiﬁed BODE index
as staging systems of COPD.
Background: Chronic obstructive pulmonary disease (COPD) is characterized by persistent
airﬂow limitation. The degree of airﬂow limitation was poorly predictive of dyspnea and quality
of life. The BODE index was the ﬁrst multidimensional assessment system for COPD. Cardiopul-
monary exercise testing (CPET) is the most comprehensive, and correlates best with the symptoms
of COPD. In this regard, two novel mBODE indices were constructed by replacing 6MWT with
_VO2 peak expressed either as the percentage of predicted values (mBODE%) or as the absolute val-
ues in ml/min/kg (mBODE).
Methods: This study included 28 patients with a wide range of severities of COPD. Cardiopul-
monary exercise test and pulmonary functions were done. GOLD spirometric staging and combined
assessment grouping were calculated then compared with the two mBODE indices.
Results: Moderate agreement between the GOLD combined assessment grouping and GOLD
spirometric staging systems and between mBODE and mBODE% in stratifying severity of COPD
patients was observed. Evaluation of mBODE index as predictors of severity of COPD using
GOLD spirometric staging as a diagnostic predictor of COPD revealed that mBODE index was
100% sensitive. However, 59.1% and 72.2% speciﬁcity were found for mBODE _VO2 ml=min=kg
and mBODE _VO2% predicted, respectively.
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Conclusion: Multidimensional staging system taking into account the exercise pulmonary func-
tion tests is better than unidimensional systems based on the resting pulmonary function tests only.
Therefore this suggests the need for integration of the novel multidimensional approach in the diag-
nostic guidelines of COPD.
ª 2014 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.
822 H.E-S. Abdel-Aaty et al.
Open access under CC BY-NC-ND license.Introduction
Chronic obstructive pulmonary disease (COPD) is one of the
most important respiratory conditions, presenting high mor-
bidity and mortality rates globally with higher prevalence and
mortality rates being expected in the forthcoming years [1].
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) [2] recommends that the assessment of severity of
COPD be based on a physiological variable, post bronchodila-
tor forced expiratory volume in the ﬁrst second (FEV1) in per-
cent of predicted. FEV1 correlates poorly to all the things that
matter to patients: symptoms, quality of life, exacerbation fre-
quency, and exercise intolerance. COPD is now recognized to
have systemic manifestations that are not reﬂected by the
FEV1 [3]. Therefore, GOLD 2011 document proposed a new
classiﬁcation system for COPD, combining symptom assess-
ment and exacerbation risk including spirometry to identify dis-
ease severity. The new assessment categorizes patients into one
of four groups: (A) low risk, less symptoms; (B) low risk, more
symptoms; (C) high risk, less symptoms; (D) high risk, more
symptoms [2]. Celli et al. [4] developed the BODE multidimen-
sional index based on four relevant variables related to COPD
mortality that involves both pulmonary and systemic factors:
body mass index (B of body mass index), airﬂow obstruction
(O of obstruction), dyspnea (D of dyspnea) and exercise capac-
ity (E of exercise). They showed that this index is a better
predictor of mortality for COPD patients than the classical var-
iable (FEV1) alone. Besides, the BODE Index is easily applica-
ble [4]. The 6-min walk test (6MWT) is a marker for the exercise
capacity of COPD patients in the BODE Index. However,
6MWT is a submaximal test, dependent on the individual moti-
vation and may not express the real physical capacity of the
patient [5]. Cardiopulmonary exercise testing (CPET) is consid-
ered as the gold standard to study a patient’s level of exercise
limitation and its causes. It provides a comprehensive assess-
ment of the integrative responses involving the pulmonary, car-
diovascular, haemopoietic, neuropsychological and skeletal
systems [6]. Cardoso et al. recently developed a modiﬁed BODE
index (mBODE) by replacing the 6MWD with _VO2. An excel-
lent correlation between BODE and mBODE when the _VO2
value was expressed as % predicted was reported (mBODE%),
which was better than that with mBODE when _VO2 was
expressed in ml/kg/min [5].
Hence the aim of this study was to compare GOLD classi-
ﬁcation versus the modiﬁed BODE index as staging systems of
COPD, in a purpose of evaluation of the two modiﬁed BODE
indices in a group of patients with stable COPD.
Patients and methods
The study was carried out in the Department of Chest Disease,
Faculty of Medicine, Menouﬁya University. 28 patients with a
wide range of severity of COPD (3 female and 25 male) diag-
nosed according to the GOLD consensus [2] were recruited
from outpatient clinic between January 2011 and February
2012.
All patients gave written informed consent, and the study
protocol was approved by the Ethics Committee of the Faculty
of Medicine, Menouﬁya University.Exclusion criteria were:
Unstable coronary artery disease, history of congestive heart
failure, signiﬁcant pulmonary disease other than COPD, sig-
niﬁcant orthopedic or neurological disease, renal, hepatic, or
other medical disease.All the patients were subjected to
1- Spirometric measurements: performed using the COS-
MED Quark CPET C12 (Cosmed, Rome, Italy) prior
to the exercise test. FEV1, forced vital capacity (FVC),
FEV1/FVC, and maximal voluntary ventilation (MVV)
were recorded.
2- Cardiopulmonary exercise testing: performed using a
treadmill The COSMED Quark CPET C12 (Cosmed,
Rome, Italy), with patients breathing room air. For
the exercise test, the patient had to be on a treadmill
and attached to a 12-lead ECG, blood pressure cuff,
heart rate monitor, pulse oximeter and a rubber mask
to measure respiratory gases (O2 and CO2) breath-by-
breath. The exercise test was performed according to
maximal incremental treadmill protocol in which the
speed is kept constant at 3.5 mph, and the grade of
treadmill was increased by 1% every minute, until the
maximal effort that the patient could support was
reached, according to ATS guidelines that recommend
the modiﬁed Balke protocol, in which a ﬁxed treadmill
speed is chosen and the treadmill grade is increased by
a constant amount each minute [7]. _VO2 max was
derived from CPET. _VO2 max was expressed as an abso-
lute value (in ml/min/kg) and as a percentage of the pre-
dicted value.
Patients were stratiﬁed according to GOLD spirometric
staging system [2] and according to the new GOLD combined
assessment system [2] using GOLD stage as risk indicator and
mMRC dyspnea scale as symptoms’ indicator.
Measurements for modiﬁed BODE index using (A)
Nutritional status: assessed by calculating body mass index
(BMI). BMI was obtained by dividing body weight in
kilograms by height in square meters (kg/m2) [4]. If
BMI < 21 = score 0. If BMIP 21 = score 1. (B) FEV1%
predicted [4]: if >65%= score 0, 50–64%= score 1, 36–49
= score 2, 635 = score 3. (C) Dyspnea: Basal dyspnea was
assessed using the modiﬁed Medical Research Council
(MMRC) scale [2]. Scale 0–1 = score 0, Scale 2 = score 1,
Scale 3 = score 2, Scale 4 = score 3. (D) The values of _VO2
max in ml/min/kg were therefore stratiﬁed according to a pre-
vious methodology by Cardoso et al. [5] as follows: score
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Comparison of GOLD classiﬁcation and modiﬁed BODE index 823=P 25 ml/min/kg; score 1 = 20–25 ml/min/kg; score 2 =
5–20 ml/min/kg; score 3 = 6 15 ml/min/kg. Similarly, values
f _VO2 max% predicted were stratiﬁed [5] as follows: score
=P 70%pred; score 1 = 60–69%pred; score 2 = 40%–
9%pred; score 3 = 6 40%pred. The mBODE indices were
alculated as the sum score ranging from 1 to 10. The scale
as then divided into quartiles, with the ﬁrst quartile corre-
ponding to scores of 0–2 points, the second quartile to scores
f 3–4 points, the third quartile to scores of 5–6 points, and the
ourth quartile to scores of 7–10 points [5].
tatistical analysis
ata were coded and analyzed using SPSS 17. Data were sum-
arized using mean and standard deviation for quantitative
ariables, numbers and percentage for qualitative variables.
omparison between groups was done using student-t tests,
hi-square test for qualitative variables and analysis of variants
ANOVA) with multiple comparisons. Correlation statistics
as used. Kappa coefﬁcient of agreement was used to measure
he agreement between the evaluations of two raters when both
re rating the same object. A value of 1 indicates perfect
greement. A value of 0 indicates that agreement is no better
han chance. Value of 0.01–0.20 indicates slight agreement,
.21–0.40 fair agreement, 0.41–0.60 moderate agreement,
.61–0.80 substantial agreement, 0.81–0.99 almost perfect
greement [8].
esults
he studied patients were 25 males representing 89.3% and 3
emales representing 10.7%. Their mean age was 52.2 ±
2.5 years with a range of 25–78 years. The mean BMI was
7.3 ± 6.1 kg/m2 with a range of 21–44.7 kg/m2. The mean
EV1/FVC ratio of the studied patients was 54.8 ± 27.3, the
ean FEV1% was 52.2 ± 9.9 and that of _VO2 max (ml/min/
g) was 15.2 ± 14.8, _VO2 max (% predicted) mean was
7.7 ± 17.5. As regards MMRC, it was 2.1 ± 0.8.
The GOLD spirometric staging showed that most of the
tudied patients were in the GOLD stage II (39.3%) then stage
II was 28.6%, stage IV was 17.9% and stage I was 14.3%.
hen using combined assessment GOLD grades most of the
tudied patients were in the D grade (43%) then grade B was
36%, GOLD grade A was 18% and grade C was only 3%.
(Fig. 1) When comparing GOLD grading and GOLD spiro-
metric staging systems, there was a statistically signiﬁcant
difference between grade C, stage 3 and grade D, stage 4 as
shown in Table 1. On applying Cohen’s Kappa coefﬁcient of
agreement to measure the agreement between the evaluations
of GOLD grading and GOLD spirometric staging systems, it
was found to be 0.426 indicating moderate agreement in strat-
ifying severity of COPD patients between the two methods.
Number of observed agreements was 16 (57.14%) of patients
(Table 2).
Table 3 shows the correlation between resting pulmonary
function tests and exercise testing parameters, there was a
signiﬁcant positive correlation between the _VO2 max (%
predicted) and both FEV1%, FEV1/FVC. Statistical compari-
son between different GOLD stages and grades as regards _VO2
max is shown in Tables 4 and 5 revealed that there was no
statistically signiﬁcant difference between different GOLD
stages as regards _VO2 max but it was observed that _VO2
max (% predicted) decrease with increasing GOLD stage
and not with GOLD grade. In Fig. 2, upon calculating modi-
ﬁed BODE index using _VO2 max% predicted (ml/min/kg), it
was found that mild stages (1st and 2nd quartiles) measured
21.5% while severe stages (3rd, 4th quartiles) measured
78.6%. Calculating modiﬁed BODE index using _VO2 max%
predicted, it was found that mild stages (1st and 2nd quartiles)
measured 35.7% while severe stages (3rd, 4th quartiles) mea-
sured 64.3%. When comparing between mBODE index
( _VO2 ml=min=kg) and mBODE index ( _VO2% predicted), it
was found that number of patients in the 1st quartile was 1
using either _VO2 ml=min=kg or _VO2% predicted while in
the 2nd quartile it was 5 using _VO2 ml=min=kg, 9 using
_VO2% predicted. In the 3rd quartile it was 12 using
_VO2 ml=min=kg, 10 using _VO2% predicted. In the 4th quartile
it was 10 using _VO2 ml=min=kg and 8 using _VO2 max% pre-
dicted. Kappa coefﬁcient of agreement was 0.451 indicating
moderate agreement in stratifying severity of COPD patients
as shown in Table 6.
The non severe groups (GOLD I,II and GOLD A,B)
accounted for 53.6% of patients for each while with mBODE
it was 21.5% when _VO2 max% predicted (ml/min/kg) was used
and 35.7% when _VO2% of predicted was used. The severe
groups (GOLD III,IV and GOLD C,D) accounted for
46.5% of patients for each while with mBODE it was 78.6%Stage 1
14.3%
Stage 2
39.3%
Stage 3
28.6%
Stage 4
17.9%
GOLD stages
A 
17.9%
B 
35.7%
C 
3.6%
D 
42.9%
GOLD grades
Figure 1 GOLD staging and GOLD combined assessment grading of the studied patients (n= 28).
when _VO2 max (ml/min/kg) was used and 64.3% when _VO2%
of predicted was used. Kappa coefﬁcient of agreement revealed
fair agreement between either GOLD staging or GOLD com-
bined assessment grades and the mBODE index using
_VO2 ml=min=kg, while it showed moderate agreement between
either GOLD staging or GOLD combined assessment groups
and the mBODE index using _VO2% of predicted in stratifying
the severity in COPD patients as shown in Tables 7–10.
Evaluation of mBODE index using _VO2 ml=min=kg and
_VO2 max% predicted as predictors of severity of COPD using
GOLD spirometric staging as a diagnostic predictor of COPD
in Table 11 revealed that mBODE index using either
_VO2 ml=min=kg or _VO2% predicted was 100% sensitive.
However, 59.1% and 72.2% speciﬁcity were found for
mBODE ( _VO2 ml=min=kg) and mBODE ( _VO2% predicted)
respectively. The accuracy of mBODE ( _VO2% predicted)
was 82.1% while that of mBODE ( _VO2 ml=min=kg) was
67.9%.
Discussion
GOLD spirometric staging showed that most of the studied
patients were in the 2nd GOLD stage (39.3%), while in using
combined assessment GOLD groups most of the studied
patients were in the D group (43%). This indicates that GOLD
spirometric staging underestimates the severity of COPD
ignoring other physiological, psychological and exacerbation
risk indicators. This was in line with the studies done by
Johannessen et al. [9] and Lange et al. [10] comparing between
2011 and 2007 GOLD for predicting mortality and hospitaliza-
tion, found that the majority of the studied patients were in the
more severe groups using GOLD 2011. A majority of the pop-
ulation was in old GOLD 2007 stage 2, and 10% of these
patients were classiﬁed as severe COPD (groups C and D)
when using the new GOLD criteria taking into account exac-
erbation history and dyspnea. It means that GOLD 2007
underestimates the severity of COPD.
The severity stratiﬁcation should not rely only on objective
criteria but also on subjective data as perceived by the patient;
that is what was taken in consideration with the new GOLD
2011 combined assessment when perception of dyspnea was
added to the combined assessment. Still both the old and the
new GOLD do not take into account the fundamental defect
in COPD patients; exercise capacity and oxygen consumption.
Also, there are suggested reﬁnements that appeared discussing
some conﬂicts in the new GOLD combined assessment groups.
Kim et al. [11] and Muellerova et al. [12] suggested that reﬁne-
ment for differentiating symptom groups would be needed, the
change of cutpoint for mMRC from 2 to 1 because an mMRC
of 1 corresponds to a CAT of 10 based on the CAT score is a
multidimensional method. In the current study, when compar-
ing GOLD grading and GOLD spirometric staging systems,
there was statistically signiﬁcant difference between grade C,
stage 3 and between grade D, stage 4. This was in line with
Table 1 Comparison between GOLD combined assessment
grading and GOLD spirometric staging systems.
GOLD group GOLD stage X2-test
A/1 5 4 P= 0.716
B/2 10 11 P= 0.783
C/3 1 8 P= 0.011*
D/4 12 5 P= 0.042*
* Signiﬁcant
Table 2 Distribution of patients according to GOLD com-
bined assessment grouping and GOLD staging of COPD.
GOLD grade Total
A B C D
GOLD stage 1 2 2 4
2 3 8 11
3 1 7 8
4 5 5
Total 5 10 1 12 28
Kappa coeﬃcient of agreement 0.4266
Table 3 Correlation between pulmonary function tests
(FEV1% and FEV1/FVC) and modiﬁed BODE index
parameters.
FEV1% FEV1/FVC
_VO2 max (ml/min/kg) R 0.338 0.338
P 0.078 0.079
_VO2 max (% predicted) R 0.476 0.444
P 0.011* 0.018*
MMRC R 0.360 0.029
P 0.060 0.883
BMI R 0.296 0.465
P 0.126 0.013*
* Signiﬁcant
Table 4 Statistical comparison between different GOLD
stages as regards _VO2 max of the studied patients.
GOLD stage No Mean SD F P
_VO2 max (ml/min/kg) 1 4 19.4 5.7 1.437 0.257
2 11 14.7 5.2
3 8 15.1 4.0
4 5 13.0 3.6
_VO2 max (% predicted) 1 4 67.5 17.6 2.468 0.086
2 11 46.3 17.8
3 8 44.8 12.7
4 5 40.0 16.6
Table 5 Statistical comparison between different GOLD
grades as regards _VO2 max of the studied patients.
GOLD grade No Mean SD F P
_VO2 max (ml/min/kg) A 5 17.0 7.4 0.724 0.548
B 10 15.5 4.8
C 1 19.2
D 12 13.9 3.7
_VO2 max (% of predicted) A 5 48.8 24.0 0.687 0.569
B 10 53.5 18.4
C 1 47.0
D 12 42.6 14.4
Group C is excluded from the comparison because of small
number.
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32.1%
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35.7%
Quarle 4
28.6%
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17.9%
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35.7%
mBODE (ml/min/kg)
Figure 2 Modiﬁed BODE index using _VO2 max% predicted (ml/min/kg) and using _VO2 max (% predicted) of the studied patients
(n= 28).
Table 6 Distribution of patients according to mBODE index using _VO2 ml=min=kg and mBODE index using _VO2% of predicted.
Modiﬁed BODE index ( _VO2%) Modiﬁed BODE index ( _VO2 ml=min=kg) Total
1 2 3 4
Quartiles 1 1 1
2 3 6 9
3 5 5 10
4 3 5 8
Total 4 11 8 5 28
Kappa coeﬃcient of agreement 0.451
Comparison of GOLD classiﬁcation and modiﬁed BODE index 825Han et al. [13] in the COPD Gene study where they found that
GOLD grade C was small compared with the other groups.
Grade C comprises subjects with little evidence of dyspnea,
and may have been underrepresented in community studies,
hence, the prevalence of group C might have been falsely
low. Kappa coefﬁcient of agreement between the evaluations
of GOLD grading and GOLD spirometric staging systems
was 0.426 indicating moderate agreement in stratifying severity
of COPD patients.
A signiﬁcant positive correlation between the FEV1%,
FEV1/FVC and the _VO2 max(% predicted) was demonstrated
in this study. There was a negative correlation of mMRC with
the FEV1% that was not signiﬁcant. This was in accordance
with Metin et al. [14], Yazici et al. [15] who found a signiﬁcant
correlation between FEV1 and _VO2 performing CPET using a
symptom limited incremental exercise test. In the current study,
there was a signiﬁcant positive correlation between the FEV1/
FVC and BMI meaning that as long as there is improvement
in the BMI there will be an increase in the FEV1/FVC ratio.
This was in accordance with Helala et al. [16] study of the rela-
tion between body mass index, waist circumference and spirom-
etry in COPD patients with BMI mean (±SD) value of
26.6 ± 9.4 kg/m2.
In the present study statistical comparison between differ-
ent GOLD stages and grades as regards _VO2 max% predicted
showed that _VO2 max% decreased with increasing GOLD
stage and not with GOLD grade. This was in accordance with
Negm et al. [17], Metin et al. [14] who found a signiﬁcant dif-
ference between mild, moderate and severe groups as regards
_VO2% of predicted indicating that with increasing severity of
COPD there was progressive decrease in _VO2% of predicted.
In Oga et al.’s study [18], disease severity was considered
according to the mortality prediction. It was reported that
the mortality predictive property of exercise capacity ( _VO2
max) might be stronger than different multidimensional
staging.Table 7 Distribution of patients according to GOLD staging and modiﬁed BODE index using _VO2 ml=min=kg.
Modiﬁed BODE index using _VO2 ml=min=kg GOLD staging Total
1 2 3 4
Quartiles 1 1 1
2 2 3 5
3 1 7 4 12
4 1 4 5 10
Total 4 11 8 5 28
Kappa coeﬃcient of agreement 0.275 (Fair)
Mild stages (1st and 2nd quartiles) measured 21.5%, 35.7%
while severe stages (3rd, 4th quartiles) measured 78.5%, 64.3%
when calculating modiﬁed BODE index using _VO2 max
(ml/min/kg) and using _VO2 max% predicted respectively.
Kappa coefﬁcient of agreement between the two methods
was 0.451 indicating moderate agreement in stratifying severity
of COPD patients. This was matching with Lopez-Campos
et al. [19] a cross-sectional study on 169 COPD patients
reported an excellent correlation between the two mBODE
indices with each other and with the original BODE index.
As for the two mBODE indices, the degree of agreement was
low, despite a high degree of correlation. Kappa coefﬁcients
were signiﬁcantly low in the entire study cohort, but improved
in patients with advanced GOLD stages. Differences with the
original BODE were higher for the mBODE than for the
mBODE%. In their study a cycle ergometer was used for
_VO2 peak stratiﬁcation instead of a treadmill.
The mBODE index using either _VO2 ml=min=kg or _VO2%
predicted was 100% sensitive using GOLD spirometric staging
as a diagnostic predictor of COPD meaning that it correctly
identiﬁes all the disease stratiﬁcation in COPD patients, so it
never underestimates the COPD GOLD spirometric staging.
However, 59.1% and 72.2% speciﬁcity were found for
mBODE _VO2 ml=min=kg and mBODE _VO2 max% predicted
respectively, meaning that a proportion of patients with certain
mBODE quartile were found to be in less severe stage by
GOLD staging system.
As far as we know, this study is the ﬁrst one to evaluate the
relation between mBODE index and GOLD stratiﬁcation of
COPD severity. Many studies evaluated the original BODE
Table 8 Distribution of patients according to GOLD staging and modiﬁed BODE index using _VO2% predicted
Modiﬁed BODE score using _VO2% predicted GOLD staging Total
1 2 3 4
Quartile 1 1 1
2 3 6 9
3 5 5 10
4 3 5 8
Total 4 11 8 5 28
Kappa coeﬃcient of agreement 0.451 (moderate)
Table 9 Distribution of patients according to GOLD combined assessment grouping and modiﬁed BODE index using
_VO2 ml=min=kg.
Modiﬁed BODE score ( _VO2 ml=min=kg) GOLD grade Total
A B C D
Quartiles 1 1 1
2 3 2 5
3 1 7 1 3 12
4 1 9 10
Total 5 10 1 12 28
Kappa coeﬃcient of agreement 0.296
Table 10 Distribution of patients according to GOLD combined assessment grouping and modiﬁed BODE index using _VO2% of
predicted.
Modiﬁed BODE score ( _VO2%) GOLD group Total
A B C D
Quartiles 1 1 1
2 3 6 9
3 1 4 1 4 10
4 8 8
Total 5 10 1 12 28
Kappa coeﬃcient of agreement 0.4237
Table 11 Evaluation of modiﬁed BODE index as a predictor of severity of COPD using GOLD spirometric staging as a diagnostic
predictor of COPD.
Sensitivity Speciﬁcity +ve predictive value ve predictive value Accuracy
mBODE index using _VO2 ml=min=kg 100% 59.1% 40.0% 100% 67.9%
Modiﬁed BODE index using _VO2% of predicted 100% 72.2% 66.7% 100% 82.1%
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index. Among these studies Khattab et al. [20], Celli et al. [4]
reported that BODE staging system helps to better predict hos-
pitalization, mortality in patients with COPD.
In the present study the non severe groups (GOLD I,II and
GOLD A,B) accounted for 53.6% of patients for each, while
with mBODE the non severe 1st and 2nd quartiles, accounted
for 21.5% when _VO2 max (ml/min/kg) was used and 35.7%
when _VO2% of predicted was used. The severe groups (GOLD
III,IV and GOLD C,D) accounted for 46.5% of patients for
each, while the 3rd and 4th quartiles counted by mBODE
accounted for 78.6% when _VO2 max (ml/min/kg) was used
and 64.3% when _VO2% of predicted was used. The Kappa
coefﬁcient of agreement was fair between either GOLD staging
or GOLD combined assessment groups and the mBODE index
using _VO2 ml=min=kg, while it showed moderate agreement
between either GOLD staging or GOLD combined assessment
groups and the mBODE index using _VO2% of predicted in
stratifying the severity in COPD patients. This was explained
by the multidimensional factors studied by the mBODE over
the mere spirometry in GOLD stage and over the risk, symp-
tom factors added by combined assessment GOLD groups
that takes into account beside spirometric GOLD stage the
mMRC dyspnea scale. Modiﬁed BODE indices take into
account beside spirometric GOLD stage and mMRC dyspnea
scale, the BMI as nutritional indicator and the _VO2 max which
is the best index of aerobic capacity and the gold standard for
cardiorespiratory ﬁtness. In Oga et al.’s study [18], they postu-
lated that multidimensional staging is superior to the current
means of disease staging based on the level of FEV1. It was
reported that the mBODE index was superior to the others
for its discriminative property with stronger predictive proper-
ties than those of FEV1 and MRC. On the opposite side Faga-
nello et al. [21], Motegi et al. [22] reported that most of their
patients had severe or very severe disease according to GOLD,
but only smaller proportion were classiﬁed in the higher
BODE scores. This was explained by the relatively different
anthropometric measurements of the studied population.
In the present study mBODE index using _VO2% predicted
showed better correlation with FEV1, FEV1/FVC and higher
coefﬁcient of agreement with GOLD spirometric staging,
GOLD combined assessment grading system, and a higher
speciﬁcity, positive predictive value and overall accuracy than
mBODE index using either _VO2 ml=min=kg. Neder et al. [23],
Cardoso et al. [5] in the evaluation of aerobic impairment in
patients with respiratory diseases conclude that the loss of aer-
obic capacity ( _VO2 max% predicted) should be used instead of
the traditional method ( _VO2 max, in ml/min/kg). This may be
explained by the fact that _VO2 max is affected by age, sex,
muscle mass, and conditioning status; the _VO2 max% pre-
dicted percent of predicted may yield better risk stratiﬁcation
than the absolute value [24] since it is believed to be more
appropriate for intersubject comparisons.
Conclusion
The mBODE index using either _VO2 ml=min=kg or _VO2
max% predicted was 100% sensitive. However, 59.1% and
72.2% speciﬁcity was found for mBODE _VO2 ml=min=kg
and mBODE _VO2 max% predicted respectively emphasizing
the upper hand of _VO2% of predicted. The accuracy of
mBODE _VO2 % predicted was 82.1% while that of mBODE
_VO2 ml=min=kg was 67.9%. Multidimensional staging system
taking into account the exercise pulmonary function tests is
better than unidimensional systems based on the resting
pulmonary function tests only.
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